Compare $AKTX vs $PTN | Chartloom

Compare

$AKTX vs $PTN

Akari Therapeutics PLC · Palatin Technologies Inc

AKTX

Akari Therapeutics PLC

PTN

Palatin Technologies Inc

Compare $AKTX vs $PTN

Comparing Akari Therapeutics PLC and Palatin Technologies Inc

AKTXAkari Therapeutics PLC

PTNPalatin Technologies Inc

AKTXAkari Therapeutics PLC

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-24.4%

52W performance

-78.5%

FCF yield

-63.0%

PTNPalatin Technologies Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

3581.2%

YTD performance

-46.4%

52W performance

19.6%

FCF yield

-88.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKTX

PTN

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

PTN

Palatin Technologies Inc

Market Cap

AKTX$17M

PTN$15M

Enterprise Value

AKTX$10M

PTN$8M

Price

AKTX$8.77

PTN$8.60

P/E Ratio

AKTXN/A

PTNN/A

P/S Ratio

AKTX0.00x

PTN1.16x

EV/Sales

AKTX0.00x

PTN0.59x

EV/EBITDA

AKTX0.00x

PTN0.18x

P/B Ratio

AKTX0.83x

PTN1.57x

P/FCF Ratio

AKTXN/A

PTNN/A

EV/FCF

AKTX-0.94x

PTN-0.58x

PEG Ratio

AKTXN/A

PTNN/A

Forward P/E (NTM)

AKTXN/A

PTNN/A

Forward P/S (NTM)

AKTXN/A

PTNN/A

Revenue (TTM)

AKTX$0

PTN$13M

Revenue Growth (YoY)

AKTXN/A

PTN3581.2%

Forward Rev Growth

AKTX137.9%

PTN-58.6%

Gross Margin (TTM)

AKTX0.0%

PTN97.8%

Operating Margin (TTM)

AKTX0.0%

PTN0.0%

EBITDA Margin (TTM)

AKTX0.0%

PTN-65.3%

Net Margin (TTM)

AKTX0.0%

PTN-63.5%

FCF Margin (TTM)

AKTXN/A

PTN-103.0%

Net Income (TTM)

AKTX$-31M

PTN$-8M

FCF (TTM)

AKTX$-11M

PTN$-14M

EPS (TTM)

AKTX-$0.40

PTN-$2.14

ROE (TTM)

AKTX-14745.0%

PTN-5370.0%

ROA (TTM)

AKTX-7470.0%

PTN-5808.0%

ROIC (TTM)

AKTX-14027.0%

PTN-5370.0%

Cash

AKTX$8M

PTN$7M

Debt

AKTX$693K

PTN$0

Net Cash/Debt

AKTX$7M

PTN$7M

Current Ratio (TTM)

AKTX0.60x

PTN5.04x

Quick Ratio (TTM)

AKTX0.56x

PTN4.93x

Debt/Equity (TTM)

AKTX0.04x

PTN2.00x

Debt/Assets (TTM)

AKTX0.0%

PTN0.0%

Interest Coverage (TTM)

AKTXN/A

PTNN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

PTN0.00x

Beta

AKTX1.48

PTN0.84

52W Performance

AKTX-78.5%

PTN19.6%

YTD Performance

AKTX-24.4%

PTN-46.4%

% from 52W High

AKTX-79.5%

PTN-72.3%

% from 52W Low

AKTX190.4%

PTN53.3%

Asset Turnover (TTM)

AKTX0.00x

PTN0.97x

FCF Yield (TTM)

AKTX-63.0%

PTN-88.7%

Earnings Yield (TTM)

AKTX-181.3%

PTN-54.7%

Dividend Yield (TTM)

AKTXN/A

PTNN/A

Rule of 40

AKTX0.0

PTN3,478.2

EV/GP/RG

AKTXN/A

PTNN/A

Ticker research

View AKTX research View PTN research

Metric	AKTX Akari Therapeutics PLC	PTN Palatin Technologies Inc
Market & Valuation
Market Cap	$17M	$15M
Enterprise Value	$10M	$8M
Price	$8.77	$8.60
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.16x
EV/Sales	0.00x	0.59x
EV/EBITDA	0.00x	0.18x
P/B Ratio	0.83x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	-0.58x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$13M
Revenue Growth (YoY)	N/A	3581.2%
Forward Rev Growth	137.9%	-58.6%
Profitability
Gross Margin (TTM)	0.0%	97.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-65.3%
Net Margin (TTM)	0.0%	-63.5%
FCF Margin (TTM)	N/A	-103.0%
Net Income (TTM)	$-31M	$-8M
FCF (TTM)	$-11M	$-14M
EPS (TTM)	-$0.40	-$2.14
ROE (TTM)	-14745.0%	-5370.0%
ROA (TTM)	-7470.0%	-5808.0%
ROIC (TTM)	-14027.0%	-5370.0%
Financial Health
Cash	$8M	$7M
Debt	$693K	$0
Net Cash/Debt	$7M	$7M
Current Ratio (TTM)	0.60x	5.04x
Quick Ratio (TTM)	0.56x	4.93x
Debt/Equity (TTM)	0.04x	2.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.84
52W Performance	-78.5%	19.6%
YTD Performance	-24.4%	-46.4%
% from 52W High	-79.5%	-72.3%
% from 52W Low	190.4%	53.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.97x
FCF Yield (TTM)	-63.0%	-88.7%
Earnings Yield (TTM)	-181.3%	-54.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,478.2
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View PTN research

Valuation

P/S Ratio

AKTX

0.00x

PTN

1.16x

EV/FCF

AKTX

-0.94x

PTN

-0.58x

Growth & revenue

Revenue Growth TTM

PTN

3581.2%

Forward Revenue Growth

AKTX

137.9%

PTN

-58.6%

Profitability & performance

Gross Margin

PTN

97.8%

AKTX

0.0%

ROE

PTN

-5370.0%

AKTX

-14745.0%

FCF Yield %

AKTX

-63.0%

PTN

-88.7%

52-Week Performance

PTN

19.6%

AKTX

-78.5%

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

PTN

Palatin Technologies Inc

Market Cap

AKTX$17M

PTN$15M

Enterprise Value

AKTX$10M

PTN$8M

Price

AKTX$8.77

PTN$8.60

P/E Ratio

AKTXN/A

PTNN/A

P/S Ratio

AKTX0.00x

PTN1.16x

EV/Sales

AKTX0.00x

PTN0.59x

EV/EBITDA

AKTX0.00x

PTN0.18x

P/B Ratio

AKTX0.83x

PTN1.57x

P/FCF Ratio

AKTXN/A

PTNN/A

EV/FCF

AKTX-0.94x

PTN-0.58x

PEG Ratio

AKTXN/A

PTNN/A

Forward P/E (NTM)

AKTXN/A

PTNN/A

Forward P/S (NTM)

AKTXN/A

PTNN/A

Revenue (TTM)

AKTX$0

PTN$13M

Revenue Growth (YoY)

AKTXN/A

PTN3581.2%

Forward Rev Growth

AKTX137.9%

PTN-58.6%

Gross Margin (TTM)

AKTX0.0%

PTN97.8%

Operating Margin (TTM)

AKTX0.0%

PTN0.0%

EBITDA Margin (TTM)

AKTX0.0%

PTN-65.3%

Net Margin (TTM)

AKTX0.0%

PTN-63.5%

FCF Margin (TTM)

AKTXN/A

PTN-103.0%

Net Income (TTM)

AKTX$-31M

PTN$-8M

FCF (TTM)

AKTX$-11M

PTN$-14M

EPS (TTM)

AKTX-$0.40

PTN-$2.14

ROE (TTM)

AKTX-14745.0%

PTN-5370.0%

ROA (TTM)

AKTX-7470.0%

PTN-5808.0%

ROIC (TTM)

AKTX-14027.0%

PTN-5370.0%

Cash

AKTX$8M

PTN$7M

Debt

AKTX$693K

PTN$0

Net Cash/Debt

AKTX$7M

PTN$7M

Current Ratio (TTM)

AKTX0.60x

PTN5.04x

Quick Ratio (TTM)

AKTX0.56x

PTN4.93x

Debt/Equity (TTM)

AKTX0.04x

PTN2.00x

Debt/Assets (TTM)

AKTX0.0%

PTN0.0%

Interest Coverage (TTM)

AKTXN/A

PTNN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

PTN0.00x

Beta

AKTX1.48

PTN0.84

52W Performance

AKTX-78.5%

PTN19.6%

YTD Performance

AKTX-24.4%

PTN-46.4%

% from 52W High

AKTX-79.5%

PTN-72.3%

% from 52W Low

AKTX190.4%

PTN53.3%

Asset Turnover (TTM)

AKTX0.00x

PTN0.97x

FCF Yield (TTM)

AKTX-63.0%

PTN-88.7%

Earnings Yield (TTM)

AKTX-181.3%

PTN-54.7%

Dividend Yield (TTM)

AKTXN/A

PTNN/A

Rule of 40

AKTX0.0

PTN3,478.2

EV/GP/RG

AKTXN/A

PTNN/A

Ticker research

View AKTX research View PTN research

Metric	AKTX Akari Therapeutics PLC	PTN Palatin Technologies Inc
Market & Valuation
Market Cap	$17M	$15M
Enterprise Value	$10M	$8M
Price	$8.77	$8.60
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.16x
EV/Sales	0.00x	0.59x
EV/EBITDA	0.00x	0.18x
P/B Ratio	0.83x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	-0.58x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$13M
Revenue Growth (YoY)	N/A	3581.2%
Forward Rev Growth	137.9%	-58.6%
Profitability
Gross Margin (TTM)	0.0%	97.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-65.3%
Net Margin (TTM)	0.0%	-63.5%
FCF Margin (TTM)	N/A	-103.0%
Net Income (TTM)	$-31M	$-8M
FCF (TTM)	$-11M	$-14M
EPS (TTM)	-$0.40	-$2.14
ROE (TTM)	-14745.0%	-5370.0%
ROA (TTM)	-7470.0%	-5808.0%
ROIC (TTM)	-14027.0%	-5370.0%
Financial Health
Cash	$8M	$7M
Debt	$693K	$0
Net Cash/Debt	$7M	$7M
Current Ratio (TTM)	0.60x	5.04x
Quick Ratio (TTM)	0.56x	4.93x
Debt/Equity (TTM)	0.04x	2.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.84
52W Performance	-78.5%	19.6%
YTD Performance	-24.4%	-46.4%
% from 52W High	-79.5%	-72.3%
% from 52W Low	190.4%	53.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.97x
FCF Yield (TTM)	-63.0%	-88.7%
Earnings Yield (TTM)	-181.3%	-54.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,478.2
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View PTN research